Ironwood Pharmaceuticals | IRWD - Ordinary Share Capital


Ironwood Pharmaceuticals reported $160K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Agios Pharmaceuticals USD 58.28M 241K Sep/2025
Almirall EUR 214.79M 154.21 Jun/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amarin USD 20.8M 28K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Astellas Pharma JPY 1.79B 101.21B Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Charles River Laboratories USD 49.22M 6K Sep/2025
Exact Sciences USD 189.45M 232K Sep/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
MacroGenics USD 63.26M 62.63M Sep/2025
Moderna USD 391M 2M Sep/2025
Myriad Genetics USD 93.1M 0 Sep/2025
Pacira USD 44.9M 44.85M Jun/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Takeda JPY 1.58B 2K Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025